分组1 - Prestige Consumer Healthcare reported quarterly earnings of $1.02 per share, missing the Zacks Consensus Estimate of $1.14 per share, and down from $1.07 per share a year ago, representing an earnings surprise of -10.53% [1] - The company posted revenues of $276.99 million for the quarter ended March 2024, missing the Zacks Consensus Estimate by 3.46%, and down from $285.87 million year-over-year [2] - Prestige Consumer Healthcare shares have increased approximately 15.2% since the beginning of the year, outperforming the S&P 500's gain of 9.5% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $1.10 on revenues of $284.42 million, and for the current fiscal year, it is $4.61 on revenues of $1.16 billion [7] - The Zacks Industry Rank for Medical - Products is currently in the bottom 44% of over 250 Zacks industries, indicating that the industry outlook may impact stock performance [8]
Prestige Consumer Healthcare (PBH) Misses Q4 Earnings and Revenue Estimates